The omega-3 and omega-6 families are two parallel and unconnected chains of highly unsaturated fatty acids called HUFA (Highly Unsaturated Fatty Acids). This is the term used to describe fatty acids with 20 and 22 carbon atoms and 3, 4, 5 or 6 double bonds (Lands 2000).
HUFA are the main precursors of a series of chemical messengers called eicosanoids. These substances work in the human body rather like hormones. Eicosanoids are usually synthesised to respond to intermittent signals from cells. The strength of the response, once initiated, is limited by the ratio of precursors (omega-3 and omega-6) to inhibitors present in the tissue (Liu, Bibus et al. 2001).
Omega-3 and omega-6 eicosanoids have varied and often opposing effects. Those from omega-6 acids may lead to the aggregation of blood platelets ("pro-aggregation") and inflammation ("pro-inflammatory") (Eberhart and Dubois 1995). Those from omega-3 often have the opposite effect ("anti-aggregation" and "anti-inflammatory") (Endres 1993; James, Gibson et al. 2000).
Eicosanoids from omega-3 acids are however less powerful than those from omega-6 acids (Lands, Libelt et al. 1992; Abayasekara, Wathes et al. 1999). Because they lower the level of omega-6 precursors in tissue, omega-3 acids reduce the synthesis of eicosanoids from omega-6 acids.
The two classes of essential fatty acids follow separate metabolic pathways and have opposing physiological functions: anti-aggregation and anti-inflammatory for omega-3 acids and pro-aggregation and pro-inflammatory for omega-6 acids.
It is therefore important to attain the right balance between these acids.